G93A protein aggregates. Surprisingly, despite a robust buildup of SOD1 G93A aggregates, deletion of HDAC6 only moderately modified the motor phenotypes. These findings indicate that SOD1 G93A aggregation is not the only determining factor to drive neurodegeneration in ALS, and that HDAC6 likely modulates neurodegeneration through additional mechanisms beyond protein aggregate clearance.
a common pathological feature, namely the formation of inclusion bodies made of misfolded protein aggregates in affected neurons [6] . Supporting a relevant role of protein aggregation in neurodegeneration, most genetic mutations found in familial cases of neurodegenerative disease produce mutant proteins that are prone to misfolding and aggregation [6] . The prominent examples include SOD1 G93A for ALS and the expansion of polyglutamine tracts in huntingtin (Huntington's disease), androgen receptors (spinal and bulbar muscular atrophy) and ataxin-1 (autosomal dominant cerebellar ataxia) [1] [2] [3] [4] .
Misfolded protein-derived aggregates can form in the cytoplasm or nucleus. Once aggregates accumulate, an elaborate cellular quality control (QC) system is activated to clear these toxic entities [7, 8] . Generally, protein aggregates cannot be properly unfolded for proteasomemediated degradation. In cell models, protein aggregates are frequently concentrated to the microtubule organizing center where they are further processed by autophagy [9] . This process leads to formation of a perinuclear inclusion body, termed the aggresome, which shares some features with inclusion bodies, such as Lewy bodies, found in neurodegenerative diseases [9, 10] . Accumulating evidence suggests that the aggresome, rather than being a mere junkyard for protein aggregates, is actively processed and cleared through the coordinated actions of the proteasome and autophagy [11] .
In the cellular QC system that targets protein aggregates and damaged organelles for autophagic degradation, the ubiquitin-binding cytoplasmic deacetylase HDAC6 has emerged as an important player [12] [13] [14] [15] . HDAC6 is a component of the aggresome and Lewy bodies in Parkinson disease patients [6, 10, 15] . Through its ubiquitin-binding domain (BUZ), HDAC6 binds and facilitates the transport of ubiquitinated misfolded proteins via microtubules to form the aggresome [10] and, subsequently, coordinates the clearance of aggresomes by autophagy [11, 12, 14, 16, 17] . In this context, HDAC6 is not required for autophagy activation per se; rather, it stimulates autophagosome-lysosome fusion via an actin cytoskeleton-dependent mechanism [11, 12] . HDAC6-and ubiquitin-dependent QC autophagy is also involved in the clearance of damaged mitochondria tagged by parkin, a process implicated in early-onset Parkinson disease (AR-JP) [18] .
Collectively, these findings indicate that HDAC6 plays a central role in the clearance of cytosolic protein aggregates and, consequently, neurodegeneration induced by toxic protein aggregates. In this report, we show that genetic inactivation of HDAC6 indeed significantly inhibits the clearance of multiple forms of cytosolic aggregates in a cell model and SOD1
G93A mutant protein in a mouse ALS model. Cell-based assays reveal that HDAC6 is also required for efficient targeting of lysosomes to ubiquitinated protein aggregates, uncovering a novel regulation of autophagy-dependent inclusion body clearance. Despite a large increase in ubiquitinated SOD1
G93A protein aggregates upon HDAC6 knockout (KO), the motor phenotypes of SOD1 G93A mice are surprisingly only moderately affected by HDAC6 deletion. These results indicate that SOD1
G93A aggregation is not the only toxic factor in driving ALS pathogenesis.
Materials and Methods

Cell Lines and Plasmids
Control and HDAC6-knockdown (KD) 293T and A549 cells were prepared as described previously [10] . GFP-tagged CFTR ΔF508, AR-112Q, Htt-81Q, SOD1-G93A and ataxin1-82Q expression plasmids were prepared by Qiagen Maxi-prep kit and transfected using Fugene 6 following the manufacturer's protocols. Wild-type (WT) and HDAC6 KO murine embryonic fibroblasts (MEFs) reconstituted with various HDAC6 constructs were prepared as described previously [19] . Lipofectamine LTX (Invitrogen) was used for transfection into MEFs according to the manufacturer's protocol.
Antibodies and Reagents
The following antibodies were used: HDAC6 (H-300; Santa Cruz Biotechnology), acetyl-α-tubulin (Sigma), ubiquitin (Biomol), LAMP-1 (Hybridoma Bank, Iowa City, Iowa, USA), GFP (Roche), active-caspase 3 (Millipore), human SOD1 (Millipore) and actin (Sigma).
Animal Care and Husbandry
Mice were cared for by the animal facility at Duke University with a regular maintenance program. HDAC6 +/-female mice (129/Black Swiss or B6SJL genetic background) were mated with SOD1 G93A [B6SJL-Tg (SOD1-G93A) 1Gur/J; Jackson Laboratory] to generate litters. Because the HDAC6 gene is located on the X chromosome, we only used male mice for our experiments. This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the Animal Research Committee of Duke University (Permit No. A321-09-11). All surgery was performed under sodium pentobarbital anesthesia and all efforts were made to minimize suffering.
Cytotoxicity Assay Using Anti-Active Caspase 3 Antibody
Control and HDAC6-KD A549 cells were cultured on glass coverslips, followed by transient transfection of GFP-tagged CFTR ΔF508, AR-112Q, Htt-81Q, SOD1-G93A or ataxin1-82Q expression plasmids with or without shRNA-resistant HDAC6 expression plasmid. Cells were fixed and stained with anti-GFP (green) and anti-active caspase 3 antibody (red). Active caspase 3-positive cells were counted as dead cells.
Immunofluorescence Microscopy
Immunostaining was performed as described previously [20, 21] . Cells were cultured on glass coverslips, followed by treatment with MG132 at 2.5 μ M for 24 h. Cells were washed with PBS, incubated with growth media for 18 h to clear soluble ubiquitinated proteins, and then processed for immunostaining using anti-ubiquitin and anti-LAMP1 antibodies. Images were acquired by a spinning-disk confocal microscope (Leica DMI6000C).
Filter-Trap Assay
Filter-trap assay for aggregates was performed as previously described [22] . The total protein load was normalized to the volume of the soluble fraction.
Immunohistochemical Analysis for Mouse Spinal Cord Sections
Mice were transcardially perfused with 4% paraformaldehyde in phosphate buffer (pH 7.4). Lumbar spinal cords were dissected out and embedded in OCT compound. Frozen lumbar spinal cord tissue sections (20 μm thick) were subjected to immunostaining with anti-ubiquitin antibody followed by FITC-conjugated secondary antibody and DAPI staining. For immunohistochemical analysis, the same sections were immunostained with anti-hSOD1 antibody followed by the Vectastain ABC kit (Vector Laboratories). After immunostaining, sections were counterstained using Meyer's hematoxylin.
Rotarod Test
Mice were tested for their motor coordination using Rotarod apparatus (Ugo Basile, Comerio, Italy) with an accelerating speed protocol from 4 to 40 rpm for 5 min. The longest latency to fall from 3 trials was recorded; 180 s was chosen as the arbitrary cutoff time for disease onset [9] .
Stride Length Measurement Test
The stride test was performed as previously described [5] . Mice had their hindpaws dipped in nontoxic ink and were trained to walk across a 1-meter white board for recording footprints. Stride lengths were measured in millimeters.
Paw Grip Endurance Test
Forelimb grip strength was tested with a grip meter analysis for mouse (Bioseb) as previously described [7] . The average of 3 trials was presented.
Statistical Analysis
The two-tailed Student t test was conducted for the statistical analysis of quantitative data.
Results
HDAC6-Deficient Cells Are More Sensitive to Cytosolic Protein Aggregate-Induced Toxicity
We have previously shown that HDAC6 promotes the processing and clearance of cytosolic protein aggregates induced by proteasome inhibition [12] . To determine if HDAC6 plays a general protective role against cytoplasmic protein aggregates, we expressed several disease-associated, aggregation-prone proteins in control and HDAC6-KD 293T cells. As shown in figure 1 , immunolocalization confirmed that the cystic fibrosis transmembrane conductance regulator ΔF508 mutant (CFTR ΔF508-GFP), androgen receptor 112Q (AR-112Q-GFP) mutants, huntingtin-81Q (Htt-81Q-GFP) and superoxide dismutase 1 G93A mutant (SOD1-G93A-GFP) formed cytosolic aggregates, while ataxin-1 82Q-GFP produced nuclear aggregates. To determine the amount of aggregates, 1% SDS-insoluble fractions (marked as I) were prepared and subjected to Western blotting with a GFP antibody ( fig. 2 ai) and quantified ( fig. 2 aii) . As shown in figure 2 , HDAC6 KD increased the accumulation of the cytoplasmic type of aggregates (CFTR ΔF508 and AR-112Q) but had little effect on nuclear ataxin-1 82Q aggregates in the SDS-insoluble fraction ( fig. 2 ai, right panel). These results support the notion that HDAC6 selectively regulates the clearance of cytosolic protein aggregates, consistent with its subcellular localization [21] .
HDAC6-deficient A549 cells are more susceptible to cell death induced by proteasome inhibition [10] . If HDAC6 is selectively required for cytosolic protein aggregate clearance, it is expected that HDAC6-deficient cells would be more sensitive to toxicity caused by cytosolic aggregates than nuclear aggregates. As shown in figure 2 b, apoptosis was significantly increased in HDAC6-KD A549 cells expressing cytosolic aggregationprone proteins, CFTR ΔF508, AR-112Q, Htt-81Q and SOD1-G93A. In contrast, apoptosis induced by the nuclear aggregation-prone ataxin-1 82Q was comparable between control and HDAC6-KD A549 cells ( fig. 2 b) . Expression of a shRNA-resistant HDAC6 in HDAC6-KD A549 significantly reduced the cytotoxicity associated with CFTR ΔF508, AR-112Q and Htt-81Q, and had a more moderate effect on SOD1-G93A ( fig. 2 c-f ). As expected, HDAC6 reexpression had no effect on ataxin-1 82Q toxicity cells ( fig. 2 g ). Of note, HDAC6 KD itself did not cause cell death ( fig. 2 h) , as was previously reported [10] . These data indicate that HDAC6 plays a cytoprotective role against toxicity associated with cytosolic protein aggregates.
HDAC6 Is Required for the Proper Targeting of Lysosomes to Ubiquitinated Protein Aggregates
Autophagy is the primary cytoplasmic degradation machinery responsible for the disposal of protein aggregates [23] . It involves the formation of double-membrane vesicles that sequester cytosolic constituents to form au-tophagosome, which then fuse to lysosomes where the contents are degraded. We found that the majority of large ubiquitinated protein aggregates ( ∼ 60%) in WT MEFs were encircled by lysosomes in the perinuclear region ( fig. 3 a, b) . In contrast, lysosomes in HDAC6 KO MEFs were dispersed to the cell periphery and not concentrated to protein aggregates. This finding indicates that targeting of lysosomes to protein aggregates is defective in HDAC6 KO MEFs ( fig. 3 a, b) . Interestingly, Iwata et al. [16] also showed HDAC6 KD led to periplasmic dispersion of lysosomes. Importantly, failure to target lysosomes to protein aggregates was efficiently reversed by HDAC6-KD cells are sensitive to misfolded proteins associated with neurodegeneration. a i Control and HDAC6-KD 293T cells were transfected with GFP-fused cytosolic (GFP-CFTR ΔF508 and GFP-AR-112Q) or nuclear aggregates (GFP-ataxin-1 82Q) and fractionated into SDS soluble (S) and SDS insoluble fractions (I). Each fractionated sample was subjected to immunoblot analysis using anti-GFP, anti-HDAC6 and anti-tubulin antibodies. a ii Western blotting images were analyzed by BIO-1D TM software and relative band intensities of SDS insoluble aggregates are presented. b Control and HDAC6-KD A549 cells were transfected with cytosolic (CFTR ΔF508, AR112Q, Htt 81Q, SOD1 G93A ) or nuclear protein aggregates (ataxin-1) expression plasmids. Cells were immunostained with anti-active-caspase-3 antibody to check apoptotic cells and the average percentage of apoptotic cells from 3 independent experiments are presented with error bars indicating the standard deviation (t test: * p < 0.05, * * p < 0.01). The HDAC6 KD level was checked by Western blot using anti-HDAC6 and anti-tubulin antibodies (right panel). shRNA-resistant HDAC6 was cotransfected with CFTR ΔF508 ( c ), AR112Q ( d ), Htt 81Q ( e ), SOD1 G93A ( f ) or ataxin-1 82Q ( g ) expression plasmids in HDAC6-KD A549 cells. Apoptotic cells were stained with antiactive-caspase 3 antibody and the average percentage of apoptotic cells from 3 independent experiments are presented with error bars indicating the standard deviation (t test: * p < 0.05, * * p < 0.01). h Control and HDAC6-KD A549 cells were subjected to cytotoxicity assay using CytoTox-ONE TM . Basal cytotoxicity was measured by the percent of lactate dehydrogenase release and presented as the percent of cell death. Averages from 3 independent experiments are presented with error bars indicating the standard deviation. n.s. = Not significant.
(For figure see next page.)
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Cytoplasmic type of aggregate-prone protein Nuclear type of aggregate-prone protein the reintroduction of WT, but not catalytic inactive (CD) or ubiquitin binding-deficient (ΔBUZ) mutant HDAC6 ( fig. 3 a, b) . Taken together, these results indicate that HDAC6 is required for targeting lysosomes to protein aggregates, which could enable more efficient autophagydependent aggregate degradation. G93A mice at 21 weeks of age. As expected, a few ubiquitin-positive inclusion body-like structures were detected in the cross-sections of the lumbar spinal cord from HDAC6 WT /SOD1 G93A mice ( fig. 4 a, arrowheads, bottom-left panel). No such signal was detected in WT control mice ( fig. 4 a, top-left panel) . In stark contrast, dramatically more ubiquitinated aggregates were detected fig. 4 a, bottom-right panel) . Immunostaining with a human SOD1 antibody confirmed the accumulation of SOD1 G93A ( fig. 4 b) . Of note, similar to what we have previously reported [12] , modest ubiquitinated protein aggregates were detected in the lumbar spinal cord of HDAC6 KO mice ( fig. 4 a, top-right panel) , which, as expected, did not contain SOD1 G93A ( fig. 4 G93A double-mutant mice compared to those from SOD1 G93A single-transgenic mice ( fig. 4 c) . The same spinal cord lysates were subjected to Western blot analysis and showed that soluble SOD1 G93A proteins were not affected by HDAC6 deficiency ( fig. 4 d) . Taken together, these data demonstrate that HDAC6 deficiency causes a significant accumulation of SOD1 G93A protein aggregates in SOD1 G93A transgenic mice.
HDAC6 Moderately Affects the Pathogenesis of ALS in the SOD1
G93A Model We next investigated whether HDAC6 also modifies the motor phenotypes induced by SOD1
G93A . As shown in figure 5 a, HDAC6 KO mice did not show a significant difference from WT mice in the accelerating Rotarod test, indicating that HDAC6 inactivation by itself does not lead to a motor phenotype. We then evaluated mice produced from breeding HDAC6 KO females (129/Black Swiss) with SOD1 G93A males (B6SJL). The analysis of HDAC6 KO 
/SOD1
G93A mice showed a motor phenotype (defined as when mice could not stay on the rod for 180 s) 2 weeks earlier than SOD1 G93A single-transgenic mice did, although the difference did not reach statistical significance ( fig. 5 b) . HB-9-positive motor neurons in the spinal cords of HDAC6 KO /SOD1 G93A were reduced compared to HDAC6 WT 
G93A in 20-week-old mice ( fig. 5 c) . Thus, despite the further accumulation of protein aggregates and some reduction in motor neurons ( fig. 4 ) , the deletion of HDAC6 only moderately accelerates motor phenotypes caused by SOD1 G93A . To minimize the effect of different genetic backgrounds that may generate variation, HDAC6 KO mice were backcrossed into B6SJL for 4 generations and mated with SOD1 G93A (B6SJL) male mice. In B6SJL single-background littermates, the overall disease onset was shortened (at ∼ 14 weeks old) in contrast to the 129/Black Swiss/B6SJL triple-background mice described in the previous section (about 18 weeks of age). In the new genetic background, we performed paw grip endurance (PaGE) and stride length measurement (SLM) tests. In 14-week-old mice, we observed a statistically significant decrease in PaGE performance in SOD1 G93A mice was modest. Recently, metabolic dysregulation has been reported in an ALS mouse model where starvation could magnify the thermogenic defect in ALS mutant mice [2] . We therefore investigated whether the HDAC6 status affects the thermogenic phenotype in SOD1 G93A mice. We recorded the rectal temperature of 12-week-old mice that did not yet show motor phenotypes. As shown in figure  5 f (blue column), no significant difference in rectal temperature was detected among genotypes under fed conditions. After 24 h of fasting, rectal temperatures trended lower in all genotypes. Importantly, HDAC6
KO / SOD1 G93A mice showed a significant and prominent decrease in rectal temperature to about 32.5 ° C ( fig. 5 f, red column). This result indicates that the genetic deletion of HDAC6 modifies the thermogenic phenotype of the SOD1 G93A transgenic mouse model.
Discussion
In this report, we determined the contribution of disease-associated protein aggregates in the development of neurodegenerative disease. Through the characterization of HDAC6-deficient cells, we have shown that HDAC6 plays a cytoprotective role against toxic effects of cytosolic but not nuclear aggregate-prone proteins. These findings are consistent with the proposed role of HDAC6 in promoting ubiquitin-dependent QC autophagy that degrades protein aggregates. However, the genetic analysis of SOD1 G93A mice has revealed that a marked increase in SOD1 G93A aggregates caused by HDAC6 ablation did not lead to significant aggravation of motor phenotypes. This unexpected finding has uncovered a more complex picture of protein aggregation in neurodegenerative disease.
There are several possible mechanisms to explain the apparent uncoupling of SOD1 G93A aggregation from the motor phenotypes. First, it is possible that SOD1 G93A aggregation plays only a minor role in driving motor dysfunction under normal laboratory conditions. Accordingly, SOD1
G93A toxicity would be less sensitive to the status of HDAC6. It should be noted that in Drosophila and Caenorhabditis elegans , loss of HDAC6 significantly en-hanced the toxicity induced by transgenic α-synuclein, an aggregation-prone protein associated with Parkinson disease [26, 27] . We also observed fewer motor neurons in SOD1
G93A
, HDAC6
KO double-mutant mice than in the SOD1 G93A transgenic mice ( fig. 5 c) . Thermogenesis under starvation is also significantly reduced in HDAC6 KO / SOD1 G93A mice compared to the single-transgenic mice ( fig. 5 f) . Collectively, these findings clearly indicate a functional interaction between HDAC6 deletion and SOD1
. However, these differences did not translate HDAC6 deficiency moderately accelerates the pathogenesis of ALS disease in the mouse model. a WT and HDAC6 KO mice with 129/Black Swiss with double genetic backgrounds were subjected to the accelerating Rotarod test (4-40 rpm/300 s) at 6 months of age. The latency to fall averages are presented with error bars indicating the standard error. b 129/Black Swiss/B6SJL triple genetic background mice with the indicated genotypes were subjected to the accelerating Rotarod test (4-40 rpm/180 s) every week from 9 to 23 weeks of age. Latency to fall was recorded as the highest score of three trials and presented as the average of each group; the cutoff was 180 s. The latency to fall averages are presented with error bars indicating the standard deviation. c The mouse spinal cord sections were stained with anti-HB-9 antibody to visualize motor neurons for counting at 20 weeks of age. The quantification of motor neurons in spinal cords from the indicated genotype mouse is presented with error bars indicating standard deviation (t test: * * p < 0.01). d B6SJL single genetic background mice with the indicated genotypes were subjected to a PaGE test to measure muscle strength. Grip strength was monitored every week. The averages are presented with error bars representing standard deviation (t test: * p < 0.05). e The same cohorts were subjected to SLM tests to assess motor function. Stride length was measured every week. The averages are presented with error bars representing standard deviation (t test: * p < 0.05). f Body temperature of the indicated genotypes (12 weeks old) was measured under fed and 24-hour fasted conditions using a rectal temperature probe. The averages are presented with error bars representing standard deviation (t test: * p < 0.05). into robust motor phenotypes. Whether this differential effect of HDAC6 reflects the intrinsic difference between SOD1-G93A and α-synuclein aggregates or a more complex biology of neurodegeneration in mice remains to be determined. Secondly, HDAC6 has activities independent of autophagy. Pharmacological and genetic inhibition of HDAC6 increases the acetylation of α-tubulin at the lysine 40, which has been shown to promote intracellular trafficking and axonal transport of mitochondria and organelles [28, 29] . As defects in axonal transport have been documented in neurodegenerative diseases [30] , an increased axonal transport could potentially improve neuronal function [31] . Acetylation of α-tubulin also promotes anti-inflammatory responses [4] . Given the prominent role of neuroinflammation in the progression of ALS [32] , inhibition of HDAC6 could potentially suppress neuroinflammation. These beneficial effects caused by HDAC6 ablation could potentially alleviate the toxicity associated with SOD1 aggregates, thereby explaining the relatively mild effect of HDAC6 on modifying motor phenotypes induced by SOD1
. It is conceivable that HDAC6-selective inhibitors that promote tubulin acetylation, but do not interfere with protein aggregate clearance, could have desirable pharmacological effects on ALS or related neurodegenerative diseases.
